Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) - a survey of life raft group members.

BMC gastroenterology - 15 Nov 2022

Montoya Denisse, Call Jerry W, Eshak Jennily, Knox Pete, Luedke Maeven, Kaur Sahibjeet, Rothschild Sara, Garland Mary, Scherzer Norman J

Abstract excerpt

BACKGROUND: Due to the low mutational testing rate in patients with Gastrointestinal Stromal Tumors (GIST), The Life Raft Group (LRG), a non-profit organization that provides support, advocacy and conducts research for patients with GIST, analyzed various factors that may have an impact on patients' ability to receive mutational testing. METHODS: A survey about mutational testing for patients with GIST or their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Stromal Tumors
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 36380293
DOI: 10.1186/s12876-022-02548-8
PMCID: PMC9667594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) - a survey of life raft group members.PMID 36380293Read ↗

Barriers to Mutational Testing in Patients with Gastrointestinal Stromal Tumors (GIST) – A Survey of Life Raft Group MembersSemantic proximity Read ↗

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian surveySemantic proximity Read ↗

Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice.Semantic proximity Read ↗

The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours.Semantic proximity Read ↗

Decision-making, attitudes, and understanding among patients and relatives invited to undergo genome sequencing in the 100,000 Genomes Project: A multisite survey studySemantic proximity Read ↗

What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responses.Semantic proximity Read ↗

Factors Influencing Cancer Genetic Somatic Mutation Test Ordering By Cancer PhysiciansSemantic proximity Read ↗

Factors influencing cancer genetic somatic mutation test ordering by cancer physician.Semantic proximity Read ↗

Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.Semantic proximity Read ↗

Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey.Semantic proximity Read ↗

Controversies in the treatment of RAS wild-type metastatic colorectal cancer.Semantic proximity Read ↗

Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.